LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5

References

• Yu B, Ye X, Du Q, Zhu B, Zhai Q, Li XX. 2017. The long non-coding RNA CRNDE promotes colorectal carcinoma progression by competitively binding miR-217 with TCF7L2 and enhancing the Wnt/beta-Catenin signaling pathway. Cell Physiol Biochem. 41:2489–2502. doi:10.1159/000475941.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang R, Zhao J. 2017. The novel long noncoding RNA TUSC7 inhibits proliferation by sponging miR-211 in colorectal cancer. Cell Physiol Biochem. 41:635–644. doi:10.1159/000457938.
   PubMed Web of Science ®Google Scholar
• Qin J, Ke J, Xu J, Wang F, Zhou Y, Jiang Y, Wang Z. 2015. Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer. Onco Targets Ther. 8:3639–3648. doi:10.2147/OTT.S91560.
   PubMed Web of Science ®Google Scholar
• Yue B, Sun B, Liu C, Zhao S, Zhang D, Yu F, Yan D. 2015. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer. Cancer Sci. 106:1323–1332. doi:10.1111/cas.12759.
   PubMed Web of Science ®Google Scholar
• Shao Y, Chen H, Jiang X, Chen S, Li P, Ye M, Li Q, Sun W, Guo J. 2014. Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 35:9591–9595. doi:10.1007/s13277-014-2243-z.
   PubMedGoogle Scholar
• Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut. 2014;63:1700–1710. doi:10.1136/gutjnl-2013-305806.
   PubMed Web of Science ®Google Scholar
• Ichigozaki Y, Fukushima S, Jinnin M, Miyashita A, Nakahara S, Tokuzumi A, Yamashita J, Kajihara I, Aoi J, Masuguchi S, et al. Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma. Exp Dermatol. 2016;25:67–69. doi:10.1111/exd.12868.
   PubMed Web of Science ®Google Scholar
• Damas ND, Marcatti M, Come C, Christensen LL, Nielsen MM, Baumgartner R, Gylling HM, Maglieri G, Rundsten CF, Seemann SE, et al. SNHG5 promotes colorectal cancer cell survival by counteracting STAU1-mediated mRNA destabilization. Nat Commun. 2016;7:13875. doi:10.1038/ncomms13875.
   PubMed Web of Science ®Google Scholar
• Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, Dong JT. 2009. Implication of snoRNA U50 in human breast cancer. J Genet Genomics. 36:447–454. doi:10.1016/S1673-8527(08)60134-4.
   PubMed Web of Science ®Google Scholar
• Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, Petros J, Li Q, Vessella RL, Kibel AS, et al. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet. 2008;17:1031–1042. doi:10.1093/hmg/ddm375.
   PubMed Web of Science ®Google Scholar
• Mokutani Y, Uemura M, Munakata K, Okuzaki D, Haraguchi N, Takahashi H, Nishimura J, Hata T, Murata K, Takemasa I, et al. Down-regulation of microRNA-132 is associated with poor prognosis of colorectal cancer. Ann Surg Oncol. 2016;23:599–608. doi:10.1245/s10434-016-5133-3.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang W, Chen G, Ren F, Liang H, Dang Y, Rong M. 2016. An encapsulation of gene signatures for hepatocellular carcinoma, MicroRNA-132 predicted target genes and the corresponding overlaps. PLoS One. 11:e0159498. doi:10.1371/journal.pone.0159498.
   PubMed Web of Science ®Google Scholar
• Kaur S, Lotsari JE, Al-Sohaily S, Warusavitarne J, Kohonen-Corish MR, Peltomaki P. 2015. Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma. Clin Epigenetics. 7:20. doi:10.1186/s13148-015-0059-3.
   PubMed Web of Science ®Google Scholar
• Liu Q, Liao F, Wu H, Cai T, Yang L, Wang ZF, Zou R. 2014. Upregulation of miR-132 expression in glioma and its clinical significance. Tumour Biol. 35:12299–12304. doi:10.1007/s13277-014-2541-5.
   PubMedGoogle Scholar
• Zheng YB, Luo HP, Shi Q, Hao ZN, Ding Y, Wang QS, Li SB, Xiao GC, Tong SL. 2014. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2. World J Gastroenterol. 20:6515–6522. doi:10.3748/wjg.v20.i21.6515.
   PubMed Web of Science ®Google Scholar
• Zhang ZG, Chen WX, Wu YH, Liang HF, Zhang BX. 2014. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochem Biophys Res Commun. 454:109–114. doi:10.1016/j.bbrc.2014.10.049.
   PubMed Web of Science ®Google Scholar
• Liu X, Yu H, Cai H, Wang Y. 2014. The expression and clinical significance of miR-132 in gastric cancer patients. Diagn Pathol. 9:57. doi:10.1186/1746-1596-9-57.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu G, Shen F, Kang Y. 2014. miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol. 35:4859–4865. doi:10.1007/s13277-014-1637-2.
   PubMedGoogle Scholar
• Bhardwaj A, Singh H, Rajapakshe K, Tachibana K, Ganesan N, Pan Y, Gunaratne PH, Coarfa C, Bedrosian I. 2017. Regulation of miRNA-29c and its downstream pathways in preneoplastic progression of triple-negative breast cancer. Oncotarget. 8:19645–19660. doi:10.18632/oncotarget.14902.
   PubMedGoogle Scholar
• Deng B, Molina J, Aubry MC, Sun Z, Wang L, Eckloff BW, Vasmatzis G, You M, Wieben ED, Jen J, et al. Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA. Cell Biosci. 2014;4:35. doi:10.1186/2045-3701-4-35.
   PubMed Web of Science ®Google Scholar
• Xie X, Tang B, Xiao YF, Xie R, Li BS, Dong H, Zhou JY, Yang SM. 2016. Long non-coding RNAs in colorectal cancer. Oncotarget. 7:5226–5239. doi:10.18632/oncotarget.6446.
   PubMedGoogle Scholar
• Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi-Agro E, et al. DNA methylation silences miR-132 in prostate cancer. Oncogene. 2013;32:127–134. doi:10.1038/onc.2012.14.
   PubMed Web of Science ®Google Scholar
• Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z. 2013. Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma. Cell Signal. 25:1037–1043. doi:10.1016/j.cellsig.2013.01.019.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu H, Xie Z, Deng W, Wu C, Qin B, Hou J, Lu M. 2016. Epigenetically regulated miR-449a enhances hepatitis B virus replication by targeting cAMP-responsive element binding protein 5 and modulating hepatocytes phenotype. Sci Rep. 6:25389. doi:10.1038/srep25389.
   PubMed Web of Science ®Google Scholar
• Long X, Li Y, Qiu S, Liu J, He L, Peng Y. 2016. MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-kappaB signaling and caused opioid-induced immunosuppression in human monocytes. Transl Psychiatry. 6:e757. doi:10.1038/tp.2016.4.
   PubMed Web of Science ®Google Scholar